Concepedia

Gustavo Borjas

GB

Statistics

Publications

7

Citations

174

H-Index

7

Active since

2019

Affiliations

University of South Florida(Current)

Moffitt Cancer Center

Imperial College London

Duke University

University of Chicago

Gustavo Borjas is an author at University of South Florida specializing in oncology, checkpoint inhibitor therapy, and immunotherapy.

ORCID

Publications per year

2019–2024

7

Publications

7

Protofibril–Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation

Filip Hasecke, Chamani Niyangoda, Gustavo Borjas et al. · Angewandte Chemie International Edition · 2020 · 38 citations · Full text

, , +17

Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity

Seounghun Kang, Aslan Mansurov, Trevin Kurtanich et al. · Science Advances · 2023 · 29 citations · Full text

, , +17

Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial

Roger Li, Nancy Villa, Xiaoqing Yu et al. · Nature Medicine · 2024 · 29 citations · Full text

, , +14

A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma <i>In Situ</i> of the Bladder

Roger Li, Wade J. Sexton, Jasreman Dhillon et al. · Clinical Cancer Research · 2023 · 23 citations · Full text

, , +15

Kinetic Transition in Amyloid Assembly as a Screening Assay for Oligomer-Selective Dyes

Jeremy Barton, D. Sebastian Arias, Chamani Niyangoda et al. · Biomolecules · 2019 · 20 citations · Full text

, , +17

1–5 of 7